Screening, Early Detection, and Diagnosis of Pulmonary Arterial Hypertension: ACCP Evidence-Based Clinical Practice Guidelines Export

@article{citeulike:3787827, abstract = {Pulmonary arterial hypertension (PAH) occurs as an idiopathic process or as a component of a variety of disease processes, including chronic thromboembolic disease, connective tissue diseases, congenital heart disease, and exposure to exogenous factors including appetite suppressants or infectious agents such as HIV. This article reviews evidence for screening in susceptible patient groups and the approach to diagnosing PAH when it is suspected, and provides specific recommendations for applying this evidence to clinical practice. 10.1378/chest.126.1\_suppl.14S}, author = {Mcgoon, Michael and Gutterman, David and Steen, Virginia and Barst, Robin and Mccrory, Douglas C. and Fortin, Terry A. and Loyd, James E.}, citeulike-article-id = {3787827}, citeulike-linkout-0 = {http://dx.doi.org/10.1378/chest.126.1_suppl.14S}, citeulike-linkout-1 = {http://www.chestjournal.org/cgi/content/abstract/126/1_suppl/14S?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&fulltext=guidelines+pulmonary+hipertension&searchid=1&FIRSTINDEX=0&sortspec=relevance&resourcetype=HWCIT}, citeulike-linkout-2 = {http://view.ncbi.nlm.nih.gov/pubmed/15249493}, citeulike-linkout-3 = {http://www.hubmed.org/display.cgi?uids=15249493}, day = {1}, doi = {10.1378/chest.126.1_suppl.14S}, journal = {Chest}, keywords = {cti, diagnostic\_tools, pulmonary\_hypertension}, month = {July}, number = {1\_suppl}, pages = {14S--34}, posted-at = {2008-12-14 20:26:55}, priority = {2}, title = {Screening, Early Detection, and Diagnosis of Pulmonary Arterial Hypertension: ACCP Evidence-Based Clinical Practice Guidelines}, url = {http://dx.doi.org/10.1378/chest.126.1_suppl.14S}, volume = {126}, year = {2004} }

TY - JOUR ID - citeulike:3787827 L3 - citeulike-article-id:3787827 N2 - Pulmonary arterial hypertension (PAH) occurs as an idiopathic process or as a component of a variety of disease processes, including chronic thromboembolic disease, connective tissue diseases, congenital heart disease, and exposure to exogenous factors including appetite suppressants or infectious agents such as HIV. This article reviews evidence for screening in susceptible patient groups and the approach to diagnosing PAH when it is suspected, and provides specific recommendations for applying this evidence to clinical practice. 10.1378/chest.126.1_suppl.14S IS - 1_suppl JF - Chest EP - 34 TI - Screening, Early Detection, and Diagnosis of Pulmonary Arterial Hypertension: ACCP Evidence-Based Clinical Practice Guidelines VL - 126 SP - 14S KW - cti KW - diagnostic_tools KW - pulmonary_hypertension AU - Mcgoon, Michael AU - Gutterman, David AU - Steen, Virginia AU - Barst, Robin AU - Mccrory, Douglas AU - Fortin, Terry AU - Loyd, James PY - 2004/07/01/ UR - http://dx.doi.org/10.1378/chest.126.1_suppl.14S ER -